期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
剖宫产瘢痕妊娠患者术后采用不同避孕方式的避孕效果差异 被引量:4
1
作者 杨彩虹 李勇逵 《中国当代医药》 2018年第1期92-94,共3页
目的评价剖宫产瘢痕妊娠患者行子宫动脉栓塞术联合B超引导下清宫术后分别采用复方短效口服避孕药、左炔诺孕酮宫内缓释系统(曼月乐,IUS)及安全套和安全期避孕三种不同方式进行避孕所产生的不同的避孕效果。方法选取我院2014年8月~2016年... 目的评价剖宫产瘢痕妊娠患者行子宫动脉栓塞术联合B超引导下清宫术后分别采用复方短效口服避孕药、左炔诺孕酮宫内缓释系统(曼月乐,IUS)及安全套和安全期避孕三种不同方式进行避孕所产生的不同的避孕效果。方法选取我院2014年8月~2016年8月收治的121例剖宫产瘢痕妊娠患者,随机分为三组,分别采用每日口服复方短效口服避孕药、术后子宫内立即放置IUS及仅用安全套和安全期避孕(对照组)三种不同方式避孕,其中避孕药组39例,IUS组39例,对照组43例,对三组患者行为期12个月的随访,并检查分析其B超检查结果、意外妊娠情况以及月经量的增减变化情况。结果随访12个月后结果显示,服用避孕药组患者避孕有效率为97.4%,有1例由于漏服药物导致再发剖宫产瘢痕妊娠(CSP);IUS组患者避孕效果很好,有效率为100%;对照组避孕有效率为91%,4例发生意外妊娠,其中1例为再发剖宫产瘢痕妊娠,另外3例为宫内妊娠。其中避孕药组和IUS组避孕有效率明显高于对照组,差异有统计学意义(P<0.05)。B超监测结果显示,三组患者均未出现切口破裂或损伤的情况,亦无性生活不适主诉。三组患者术后均无月经增多,进一步比较三组月经增减变化情况,术后3、6、12个月月经量均发生减少,且IUS组减少情况明显高于对照组和避孕药组,差异有统计学意义(P<0.05)。结论瘢痕妊娠患者剖宫产后采用IUS以及口服复方短效口服避孕药避孕效果明显好于安全套及安全期避孕,安全,可靠,值得推广使用。 展开更多
关键词 剖宫产瘢痕妊娠 清宫术 左炔诺孕酮宫内缓释系统 复方短效避孕药 安全期 安全套 避孕
下载PDF
Postpartum intrauterine device contraception: A review
2
作者 Shadi Rezai Pameela Bisram +2 位作者 Hasan Nezam Ray Mercado Cassandra E Henderson 《World Journal of Obstetrics and Gynecology》 2016年第1期134-139,共6页
AIM: To review the safety (infection, perforation) and efficacy (expulsion, continuation rates, pregnancy) of intrauterine device (IUD) insertion in the postpartum period. METHODS: MEDLINE, PubMed and Google S... AIM: To review the safety (infection, perforation) and efficacy (expulsion, continuation rates, pregnancy) of intrauterine device (IUD) insertion in the postpartum period. METHODS: MEDLINE, PubMed and Google Scholar were searched for randomized controlled trials and prospective cohort studies of IUD insertions at different times during the postpartum period. Time of insertion during the postpartum period was documented speci-fically, immediate post placenta period (within 10 min), early post placenta period (10 min to 72 h), and de-layed/interval period (greater than 6 wk). Other study variables included mode of delivery, vaginal vs cesarean, manual vs use of ring forceps to insert the IUD. RESULTS: IUD insertion in the immediate postpartum (within 10 min of placental delivery), early postpartum (10 min up to 72 h) and Interval/Delayed (6 wk onward) were found to be safe and effcacious. Expulsion rates were found to be highest in the immediate postpartum groups ranging from 14% to 27%. Immediate post placental insertion found to have expulsion rates that ranged from 3.6% to 16.2%. Expulsion rate was significantly higher after insertion following vaginal vs cesarean delivery. The rates of infection, perforation and unplanned pregnancy following postpartum IUD insertion are low. Method of insertion such as with ring forceps, by hand, or another placement method unique to the type of IUD did not show any signifcant difference in expulsion rates. Uterine perforations are highest in the delayed/interval IUD insertion groups.Breastfeeding duration and infant development are not affected by delayed/interval insertion of the non-hormonal (copper) IUD or the Levonorgestrel IUD. Timing of the Levonorgestrel IUD insertion may affect breastfeeding. CONCLUSION: IUD insertion is safe and efficacious during the immediate postpartum, early postpartum and delayed postpartum periods. Expulsion rates are highest after vaginal delivery and when inserted during the immediate postpartum period. IUD associated infection rates were not increased by insertion during the postpartum period over interval insertion rates. There is no evidence that breastfeeding is negatively affected by postpartum insertion of copper or hormone-secreting IUD. Although perforation rates were higher when inserted after lactation was initiated. Randomized controlled trials are needed to further elucidate the consequence of lactation on postpartum insertion. Despite the concerns regarding expulsion, perforation and breastfeeding, current evidence indicates that a favorable risk beneft ratio in support of postpartum IUD insertion. This may be particularly relevant for women for whom barriers exist in achieving desired pregnancy spacing. 展开更多
关键词 Access to intrauterine devices contra-ception EXPULSION Intrauterine device Long acting reversible contraception Postpartum contraception Postpartum intrauterine device Postpartum intrauterine device placement Post-placental insertion
下载PDF
米非司酮用于排卵期房事后避孕的临床初步观察 被引量:24
3
作者 张晏 乔根梅 +4 位作者 朱蓬弟 张芝娟 周萍 谷炤 董琳 《中国计划生育学杂志》 1996年第1期29-31,35,共4页
观察排卵期服用300mg米非司酮进行房事后避孕的效果和对月经的影响,在对照周期、用药周期和恢复周期,血浆雌二醇(E_2)、孕酮(P)和黄体生成素(LH)浓度的变化,以及米非司酮对分泌期子宫内膜的影响。接受85名育龄妇女为受试者。60例主要观... 观察排卵期服用300mg米非司酮进行房事后避孕的效果和对月经的影响,在对照周期、用药周期和恢复周期,血浆雌二醇(E_2)、孕酮(P)和黄体生成素(LH)浓度的变化,以及米非司酮对分泌期子宫内膜的影响。接受85名育龄妇女为受试者。60例主要观察避孕效果和月经恢复情况,另25例在三个不同周期中,定期取静脉血测三种激素水平,并在服米非司酮后第4~5天,取子宫内膜进行形态学检查。共观察129个服药周期,妊娠率为0.78%。其中18个周期出现服米非司酮后阴道少量出血,但未干扰正常月经规律,无明显副反应发生。在用药周期和恢复周期中,血浆E_2、P和LH的水平未受影响。形态学检查显示子宫内膜发育延迟。本研究联合使用几种监测排卵方法,提示在排卵后72小时内服300mg米非司酮安全、有效,在分泌早期服用米非司酮可以考虑作为一月一次的避孕方法。 展开更多
关键词 米非司酮 避孕药 房事后避孕 排卵监测
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部